Objectives To examine the link between urinary incontinence (UI) and physical activity participation in women. Little research has explored this relationship, despite the long-term effects of reduced physical activity on women’s health and well-being. Design A cross-sectional survey was conducted using self-reported data collected through social media and university channels. Participants Adults aged 18 years or older identifying as women, including transgender women who had undergone gender-affirming vaginoplasty and people assigned female at birth. In total, 413 individuals completed the…
Introduction Healthcare systems increasingly screen for social needs, yet referrals often fail to connect patients with services—particularly in emergency department (ED) settings where unmet social needs are common. Our research highlights critical barriers to service connection, including unstable access to cellphones, limited internet and low digital literacy. These challenges disproportionately affect socio-economically disadvantaged groups and are associated with poorer health outcomes and more frequent ED visits. With the recognition of information and communication technology (ICT)…
Introduction Approximately 15 million people in the UK live with obesity and at least 5 million of these are people with severe obesity (PWSO). Severe obesity significantly compromises health, well-being and quality of life and reduces life expectancy. These adverse outcomes are prevented or ameliorated by weight loss, for which sustained behavioural change is the cornerstone of treatment. Several studies suggest the potential of group-based intervention in Specialist Weight Management Services (SWMS), but PWSO remain underrepresented in research, and evidence on optimal design and outcomes is…
As demand for weight-loss medicines continues to rise, the MHRA is reminding people how to use GLP-1 medicines safely, spot illegal sellers, and avoid diet changes that could interfere with their medicines.
Following in the footsteps of Gilead, Merck has signed voluntary licensing agreements to enable access to its investigational HIV PrEP pill alimatravir ahead of any regulatory submissions.
A growing network of home-sharing programs is helping people find compatible housemates. And demand is rising, driven by housing shortages, rising rents, and sales prices that affect both the old and the young.
Bill Cassidy of Louisiana chairs the Senate’s health committee. In an interview with KFF Health News’ Julie Rovner, he discusses the drug supply, his proposal to defray out-of-pocket costs, and his controversial vote to confirm Robert F. Kennedy Jr. as health secretary.
Hear from six pediatricians in measles hot spot Utah as the U.S. faces infection levels not seen in over three decades and prepares to lose its status as a country that eliminated the dangerous disease.
Scribe Therapeutics’ IPO will support a pipeline led by a genetic medicine that represses expression of its target gene without making permanent changes. Common chronic cardiometabolic conditions are Scribe’s initial focus as the biotech works to bring genetic medicines beyond rare diseases. The post CRISPR Biotech Scribe Therapeutics Writes a New Chapter With $129M IPO appeared first on MedCity News .
Sanofi has abandoned plans to seek approval for amlitelimab in atopic dermatitis, admitting that a drug once tipped as a potential blockbuster “would not represent a meaningful improvement” to existing treatments.
Unlike past healthcare tech waves sold on cost savings, AI is proving it can generate new revenue — with returns as high as 100x, according to a panel of investors at MedCity News’ Bullseye event. The post Healthcare Investors Are Rewriting the ROI Playbook from Cost-Cutting to Cash Flow appeared first on MedCity News .
July 24, 2026 - Taoyuan City, Taiwan - Sunny Pharmtech, Inc is voluntarily recalling three lots of Cyclophosphamide for Injection, USP, 1g/vial and 2g/vial, to the User Level due to the presence of particulate matter identified as steel. To date, no adverse events or injuries associated with this pa
July 24, 2026 – Shirley, NY, American Regent, Inc. is conducting a nationwide voluntary recall of a single lot of Papaverine Hydrochloride Injection, USP, 60 mg/2 mL single dose vial to the consumer level. The product is being recalled due to the presence of particulate matter identified as glass an
ARLINGTON, VA – JULY 24, 2026 – Lidl US is recalling all units of Eridanous Shortbread Cookies with Chocolate Truffle Coating & Apricot Filling 11.6 oz (330 g) box UPC 4056489125839 with foreign language ingredients and nutrition facts panel due to undeclared wheat, soy, milk, and egg allergens. Peo